Cognitive deficits and psychopathological symptoms among children with medulloblastoma

Annamária Szentes, Nikoletta Erős, Zoltán Kekecs, Zsuzsanna Jakab, Szabolcs Török, D. Schuler, P. Hauser, M. Garami

Research output: Contribution to journalArticle

Abstract

Children with medulloblastoma (MB) are predisposed for negative cognitive sequela, which has been widely identified in this population. The purpose of the present study was to explore cognitive deficits and psychopathological symptoms and analyse their relation among MB survivors. The Wechsler Intelligence Scale for Children and the Mini International Neuropsychiatric Interview (MINI-KID) was administered to 34 MB survivors to measure cognitive functioning and psychopathological symptoms. The MB survivors had lower global IQ (86.41 [79.70–93.13]) compared with the control population mean. We found impaired functioning in all IQ subscales in the MB survivors group, of which processing speed (84.15 [77.71–90.58]) was the most affected. Higher radiation dose and high-dose chemotherapy with stem cell rescue were significantly associated factors for lowered global IQ, while age at diagnosis, sex and time period from diagnosis were not significantly associated. Compulsive disorder, generalised anxiety, separation anxiety and posttraumatic stress disorder were significantly more prevalent in the MB survivor group than a group of 46 control participants. No correlation was found between the cognitive deficits and the psychopathological symptoms. Our results identify that MB survivors suffer from cognitive and psychopathological impairments, and these could exist independently from each other.

Original languageEnglish
JournalEuropean Journal of Cancer Care
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Medulloblastoma
Separation Anxiety
Wechsler Scales
Post-Traumatic Stress Disorders
Anxiety Disorders
Intelligence
Population
Stem Cells
Interviews
Radiation
Drug Therapy
Control Groups

Keywords

  • cognitive outcomes
  • IQ
  • late effects
  • medulloblastoma
  • paediatric brain tumour
  • psychopathological symptoms

ASJC Scopus subject areas

  • Oncology

Cite this

Cognitive deficits and psychopathological symptoms among children with medulloblastoma. / Szentes, Annamária; Erős, Nikoletta; Kekecs, Zoltán; Jakab, Zsuzsanna; Török, Szabolcs; Schuler, D.; Hauser, P.; Garami, M.

In: European Journal of Cancer Care, 01.01.2018.

Research output: Contribution to journalArticle

Szentes, Annamária ; Erős, Nikoletta ; Kekecs, Zoltán ; Jakab, Zsuzsanna ; Török, Szabolcs ; Schuler, D. ; Hauser, P. ; Garami, M. / Cognitive deficits and psychopathological symptoms among children with medulloblastoma. In: European Journal of Cancer Care. 2018.
@article{cc513c0440ea4cbe84cb9184f9bc8ad0,
title = "Cognitive deficits and psychopathological symptoms among children with medulloblastoma",
abstract = "Children with medulloblastoma (MB) are predisposed for negative cognitive sequela, which has been widely identified in this population. The purpose of the present study was to explore cognitive deficits and psychopathological symptoms and analyse their relation among MB survivors. The Wechsler Intelligence Scale for Children and the Mini International Neuropsychiatric Interview (MINI-KID) was administered to 34 MB survivors to measure cognitive functioning and psychopathological symptoms. The MB survivors had lower global IQ (86.41 [79.70–93.13]) compared with the control population mean. We found impaired functioning in all IQ subscales in the MB survivors group, of which processing speed (84.15 [77.71–90.58]) was the most affected. Higher radiation dose and high-dose chemotherapy with stem cell rescue were significantly associated factors for lowered global IQ, while age at diagnosis, sex and time period from diagnosis were not significantly associated. Compulsive disorder, generalised anxiety, separation anxiety and posttraumatic stress disorder were significantly more prevalent in the MB survivor group than a group of 46 control participants. No correlation was found between the cognitive deficits and the psychopathological symptoms. Our results identify that MB survivors suffer from cognitive and psychopathological impairments, and these could exist independently from each other.",
keywords = "cognitive outcomes, IQ, late effects, medulloblastoma, paediatric brain tumour, psychopathological symptoms",
author = "Annam{\'a}ria Szentes and Nikoletta Erős and Zolt{\'a}n Kekecs and Zsuzsanna Jakab and Szabolcs T{\"o}r{\"o}k and D. Schuler and P. Hauser and M. Garami",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/ecc.12912",
language = "English",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Cognitive deficits and psychopathological symptoms among children with medulloblastoma

AU - Szentes, Annamária

AU - Erős, Nikoletta

AU - Kekecs, Zoltán

AU - Jakab, Zsuzsanna

AU - Török, Szabolcs

AU - Schuler, D.

AU - Hauser, P.

AU - Garami, M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Children with medulloblastoma (MB) are predisposed for negative cognitive sequela, which has been widely identified in this population. The purpose of the present study was to explore cognitive deficits and psychopathological symptoms and analyse their relation among MB survivors. The Wechsler Intelligence Scale for Children and the Mini International Neuropsychiatric Interview (MINI-KID) was administered to 34 MB survivors to measure cognitive functioning and psychopathological symptoms. The MB survivors had lower global IQ (86.41 [79.70–93.13]) compared with the control population mean. We found impaired functioning in all IQ subscales in the MB survivors group, of which processing speed (84.15 [77.71–90.58]) was the most affected. Higher radiation dose and high-dose chemotherapy with stem cell rescue were significantly associated factors for lowered global IQ, while age at diagnosis, sex and time period from diagnosis were not significantly associated. Compulsive disorder, generalised anxiety, separation anxiety and posttraumatic stress disorder were significantly more prevalent in the MB survivor group than a group of 46 control participants. No correlation was found between the cognitive deficits and the psychopathological symptoms. Our results identify that MB survivors suffer from cognitive and psychopathological impairments, and these could exist independently from each other.

AB - Children with medulloblastoma (MB) are predisposed for negative cognitive sequela, which has been widely identified in this population. The purpose of the present study was to explore cognitive deficits and psychopathological symptoms and analyse their relation among MB survivors. The Wechsler Intelligence Scale for Children and the Mini International Neuropsychiatric Interview (MINI-KID) was administered to 34 MB survivors to measure cognitive functioning and psychopathological symptoms. The MB survivors had lower global IQ (86.41 [79.70–93.13]) compared with the control population mean. We found impaired functioning in all IQ subscales in the MB survivors group, of which processing speed (84.15 [77.71–90.58]) was the most affected. Higher radiation dose and high-dose chemotherapy with stem cell rescue were significantly associated factors for lowered global IQ, while age at diagnosis, sex and time period from diagnosis were not significantly associated. Compulsive disorder, generalised anxiety, separation anxiety and posttraumatic stress disorder were significantly more prevalent in the MB survivor group than a group of 46 control participants. No correlation was found between the cognitive deficits and the psychopathological symptoms. Our results identify that MB survivors suffer from cognitive and psychopathological impairments, and these could exist independently from each other.

KW - cognitive outcomes

KW - IQ

KW - late effects

KW - medulloblastoma

KW - paediatric brain tumour

KW - psychopathological symptoms

UR - http://www.scopus.com/inward/record.url?scp=85053399005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053399005&partnerID=8YFLogxK

U2 - 10.1111/ecc.12912

DO - 10.1111/ecc.12912

M3 - Article

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

ER -